Sirtuin signaling in hematologic malignancies
- 26 February 2021
- book chapter
- book charpter
- Published by Elsevier BV
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with ImatinibCancer Cell, 2012
- SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C ActivityCancer Cell, 2011
- SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α DestabilizationCancer Cell, 2011
- Sirtuin‐3 (SIRT3), a novel potential therapeutic target for oral cancerCancer, 2010
- Characterization of murine SIRT3 transcript variants and corresponding protein productsJournal of Cellular Biochemistry, 2010
- SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea CycleCell, 2009
- SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life SpanCell, 2009
- SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during AgingCell, 2008
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant MiceCancer Cell, 2008
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and InvasionCancer Cell, 2008